Literature DB >> 15619009

Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus-specific T cell repertoire.

M-D Nastke1, L Herrgen, S Walter, D Wernet, H-G Rammensee, S Stevanović.   

Abstract

Human cytomegalovirus (HCMV) infection or reactivation is a cause of morbidity and mortality in immunocompromised individuals. In immunocompetent individuals, in contrast, HCMV is successfully controlled by specific CD8 and CD4 T cells. Knowledge of CD8 and CD4 T cell epitopes from HCMV and their immunodominant features is crucial for the generation of epitope-specific T cells for adoptive immunotherapy and for the development of a peptide-based HCMV vaccine. Therefore, we investigated the natural frequencies of a large number of CD8 and CD4 T cell epitopes, including 10 novel ones. We determined several epitopes as immunodominant. Surprisingly, no clear hierarchies were found for CD8 T cell epitopes, indicating codominance. These results will be valuable for adoptive transfer strategies and support initiatives towards development of a peptide-based HCMV vaccine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15619009     DOI: 10.1007/s00018-004-4363-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  13 in total

1.  A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.

Authors:  Vijayendra Dasari; Kirrilee Beckett; Shane Horsefield; George Ambalathingal; Rajiv Khanna
Journal:  PLoS Pathog       Date:  2022-06-23       Impact factor: 7.464

Review 2.  In-depth summary over cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Samira Karami; Elham Roshandel; Haniyeh Ghaffari Nazari; Abbas Hajifathali; Farzaneh Tavakoli; Sayeh Parkhideh
Journal:  Virusdisease       Date:  2021-07-28

3.  Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.

Authors:  Devon J Shedlock; Kendra T Talbott; Stephan J Wu; Christine M Wilson; Karuppiah Muthumani; Jean D Boyer; Niranjan Y Sardesai; Sita Awasthi; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

4.  Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness.

Authors:  Prasanna Jagannathan; Christine M Osborne; Cassandra Royce; Maura M Manion; John C Tilton; Li Li; Steven Fischer; Claire W Hallahan; Julia A Metcalf; Mary McLaughlin; Matthew Pipeling; John F McDyer; Thomas J Manley; Jeffery L Meier; John D Altman; Laura Hertel; Richard T Davey; Mark Connors; Stephen A Migueles
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

5.  Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.

Authors:  Mark N Lee; Matthew Meyerson
Journal:  Sci Immunol       Date:  2021-01-22

6.  Age and immunity.

Authors:  Sonya Vasto; Marco Malavolta; Graham Pawelec
Journal:  Immun Ageing       Date:  2006-02-24       Impact factor: 6.400

7.  Identification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.

Authors:  Peter Braendstrup; Bo Kok Mortensen; Sune Justesen; Thomas Osterby; Michael Rasmussen; Andreas Martin Hansen; Claus Bohn Christiansen; Morten Bagge Hansen; Morten Nielsen; Lars Vindeløv; Søren Buus; Anette Stryhn
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

8.  Precision mouse models with expanded tropism for human pathogens.

Authors:  Angela Wahl; Chandrav De; Maria Abad Fernandez; Erik M Lenarcic; Yinyan Xu; Adam S Cockrell; Rachel A Cleary; Claire E Johnson; Nathaniel J Schramm; Laura M Rank; Isabel G Newsome; Heather A Vincent; Wes Sanders; Christian R Aguilera-Sandoval; Allison Boone; William H Hildebrand; Paul A Dayton; Ralph S Baric; Raymond J Pickles; Miriam Braunstein; Nathaniel J Moorman; Nilu Goonetilleke; J Victor Garcia
Journal:  Nat Biotechnol       Date:  2019-08-26       Impact factor: 54.908

9.  A HCMV pp65 polypeptide promotes the expansion of CD4+ and CD8+ T cells across a wide range of HLA specificities.

Authors:  Maurizio Provenzano; Giovanni Sais; Laura Bracci; Adrian Egli; Maurizio Anselmi; Carsten T Viehl; Stefan Schaub; Hans H Hirsch; David F Stroncek; Francesco M Marincola; Giulio C Spagnoli
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.295

10.  A Diverse Repertoire of CD4 T Cells Targets the Immediate-Early 1 Protein of Human Cytomegalovirus.

Authors:  Stefanie Ameres; Xiaoling Liang; Martina Wiesner; Josef Mautner; Andreas Moosmann
Journal:  Front Immunol       Date:  2015-11-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.